> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # NanoVation Therapeutics - URL: https://www.whiteroseintelligence.com/nanovation-therapeutics/ - Published: 1999-01-02T20:41:00.000Z - Updated: 2025-04-26T01:19:13.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #organization **NanoVation Therapeutics Inc. (NTx)** is a Canadian biotechnology company based in Vancouver, British Columbia, with an additional operation at the Research Complex at Harwell in the United Kingdom.[\[1\]](#fn1) It is focused on gene therapy and the development of "next-generation" lipid nanoparticles (LNP). It is a spin-off company of the NanoMedicines Innovation Network (NMIN).[\[2\]](#fn2) ## History NTx was co-founded by Dominik Witzigmann and Jayesh Kulkarni.[\[2:1\]](#fn2) The company was incorporated in British Columbia on September 3, 2020, and in the United Kingdom on December 7, 2021.[\[3\]](#fn3)[\[4\]](#fn4) On April 20, 2022, NTx announced its expansion into the United Kingdom by launching its so-called "NanoVation GENErator" at the Harwell Science and Innovation Campus in Oxfordshire, England.[\[2:2\]](#fn2) Innovate BC announced on September 29, 2022, that NTx would receive a $300,000 grant to further the development of mRNA vaccines.[\[5\]](#fn5) ## Organization NTx is a member organization of Life Sciences British Columbia.[\[6\]](#fn6) ### Personnel | Name | Position | Notes | | ----------------------- | ---------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | Marco Ciufolini | Co-founder, Vice President, and Board Director (Canada)[\[7\]](#fn7) | Rice University, Claude Bernard University Lyon 1, University of British Columbia (UBC) | | Pieter Cullis | Co-founder, Board Chair (Canada), and Board Director (United Kingdom)[\[8\]](#fn8) | [Acuitas Therapeutics](https://www.whiteroseintelligence.com/Acuitas-Therapeutics), UBC Department of Biochemistry & Molecular Biology, [adMare BioInnovations](https://www.whiteroseintelligence.com/adMare-BioInnovations), NanoMedicines Innovation Network (NMIN), Royal Society | | Eric Jan | Co-founder and Board Director (Canada)[\[7:1\]](#fn7) | UBC Department of Biochemistry & Molecular Biology, Stanford University | | Jayesh Kulkarni | Co-founder and Chief Scientific Officer[\[2:3\]](#fn2)[\[7:2\]](#fn7) | NanoMedicines Innovation Network (NMIN), Northern Lipids, BC Cancer Agency, University of British Columbia (UBC), Evonik, NanoMedicines Research Group | | Dominik Witzigmann | Co-founder and CEO[\[2:4\]](#fn2)[\[7:3\]](#fn7) | NanoMedicines Innovation Network (NMIN), UCL School of Pharmacy, German Cancer Research Center, University of Basel Department of Pharmaceutical Sciences, Schwank Lab, University of British Columbia (UBC),[\[9\]](#fn9) Controlled Release Society (CRS), Biozentrum, Swiss Nanoscience Institute (NSI)[\[10\]](#fn10), European Society for Nanomedicine, Swiss Academy of Pharmaceutical Sciences, German Pharmaceutical Society (DPhG) | | Marion Athané | Marketing & Events Manager[\[11\]](#fn11) | NanoMedicines Innovation Network (NMIN)[\[12\]](#fn12) | | N. D. Prasad Atmuri | Associate Principal Scientist, Chemistry[\[7:4\]](#fn7) | University College London (UCL), University of Oxford, Hetero, Syngene, University of Montreal, University of British Columbia (UBC), StrongerBC, Mitacs[\[13\]](#fn13) | | Martin Attwood | Senior Scientist, Biology[\[7:5\]](#fn7) | University College London (UCL), University of Oxford | | Hanna Barriga | Consultant, Biophysics[\[7:6\]](#fn7) | Imperial College London (ICL), Karolinska Institute, [Pfizer](https://www.whiteroseintelligence.com/Pfizer), Swedish Neutron Scattering Society (SNSS), KTH Royal Institute of Technology, New York Academy of Sciences[\[14\]](#fn14) | | Marshall Beck | Communications and IT Consultant[\[7:7\]](#fn7) | NanoMedicines Innovation Network (NMIN), Centre for Research on Latin America and the Caribbean (CERLAC), CHILD Cohort Study, Centre for Refugee Studies (CRS), North American Congress on Latin America (NACLA)[\[15\]](#fn15) | | Mayara Brandao | Senior Manager, People and Culture[\[7:8\]](#fn7) | VanHack, Community Living Society (CLS), Footprints Recruiting, Recife Center for Advanced Studies and Systems (CESAR), Grupo Contax[\[16\]](#fn16) | | David Broemeling | Vice President of Operations[\[7:9\]](#fn7) | Boreal Genomics, Creative Destruction Lab (CDL), University of British Columbia (UBC), Natera[\[17\]](#fn17) | | Frederick Campbell | Scientific Director, UK[\[18\]](#fn18) | University College London (UCL), Leiden University[\[19\]](#fn19) | | Tony Cheung | Vice President of Finance[\[7:10\]](#fn7) | TIR Systems, Pacific Cellular, Lignol Energy Corporation, Evonik, Portable Electric, Transferra Nanosciences, Canadian Fishing Company (Canfisco), Scouts Canada[\[20\]](#fn20) | | Christine DeMatteis | Lab Manager[\[7:11\]](#fn7) | [Zymeworks](https://www.whiteroseintelligence.com/Zymeworks), CARO Analytical Services[\[21\]](#fn21) | | Arpan Desai | Managing Director, UK (March 2022-January 2024)[\[2:5\]](#fn2)[\[22\]](#fn22) | Visiongain, University of Melbourne, University of Nottingham, [AstraZeneca](https://www.whiteroseintelligence.com/AstraZeneca), CamGene Therapeutics | | Allison Enjetti | Senior Project Manager[\[7:12\]](#fn7) | [AbCellera](https://www.whiteroseintelligence.com/AbCellera), U.S. President's Malaria Initiative, British Columbia Centre for Excellence in HIV/AIDS[\[23\]](#fn23) | | Don Enns | Chief Business Officer[\[7:13\]](#fn7) | Molecular You, Evonik, Life Sciences British Columbia, Genome British Columbia[\[24\]](#fn24) | | Julia Ayano Fernando | Scientist, Biology[\[7:14\]](#fn7) | HKU-Pasteur Research Pole, Swansea University | | Bruno Fonseca | RNA Director[\[7:15\]](#fn7) | University of British Columbia (UBC), McGill University, [AstraZeneca](https://www.whiteroseintelligence.com/AstraZeneca), Children's Hospital of Eastern Ontario (CHEO), [Biologic and Radiopharmaceutical Drugs Directorate](https://www.whiteroseintelligence.com/Biologic-and-Radiopharmaceutical-Drugs-Directorate) (BRDD), PrimerGen[\[25\]](#fn25) | | Georgina Girt | Senior Scientist, Formulation (UK)[\[7:16\]](#fn7) | University of Oxford, Rosalind Franklin Institute (RFI), University of Leicester[\[26\]](#fn26) | | Rupsa Gupta | Senior Associate Scientist, Formulation[\[7:17\]](#fn7) | [Precision NanoSystems](https://www.whiteroseintelligence.com/Precision-NanoSystems), NanoMat, Mitacs, Lower Mainland Bengali Cultural Society[\[27\]](#fn27) | | Graham Hayes | Senior Scientist, Formulation[\[7:18\]](#fn7) | Infineum, University of Warwick[\[28\]](#fn28) | | Kate Hollinshead | Senior Scientist, Translational Science[\[29\]](#fn29) | MedImmune, [AstraZeneca](https://www.whiteroseintelligence.com/AstraZeneca), NYU Langone Health | | Joshua Jeyakumar | Patent Associate[\[7:19\]](#fn7) | Intellectual Property Institute of Canada (IPIC), MaxVal Group, Effectual Services, Stellarix Consultancy Services[\[30\]](#fn30) | | Japneet Kaur | Preclinical Research Technician[\[7:20\]](#fn7) | \- | | Daniel Kurek | Senior Scientist III, Formulation, Team Lead[\[7:21\]](#fn7) | University of Utah, BC Research, University of British Columbia (UBC), Evonik[\[31\]](#fn31) | | Wendy Lamson | Chief Intellectual Property Officer[\[7:22\]](#fn7) | Intellectual Property Institute of Canada (IPIC), University of Ottawa, Lamson IP, Perley-Robertson, Hill & McDougall, Kirby Eades Gale Baker, Iogen, Celator Pharmaceuticals[\[32\]](#fn32) | | Rafaela Marodin | Senior Research Associate, Formulation[\[7:23\]](#fn7) | Simon Fraser University (SFU), Renaissance BioScience, University of British Columbia (UBC), [adMare BioInnovations](https://www.whiteroseintelligence.com/adMare-BioInnovations)[\[33\]](#fn33) | | Michelle Martin | Human Resources Consultant[\[7:24\]](#fn7) | Forbes Medi-Tech, thriveHR, Aquinox Pharmaceuticals[\[34\]](#fn34) | | Nigel McKenzie | Senior Manager, Operations[\[7:25\]](#fn7) | Natera, Celtic Reforestation, Quest University, BC Wildfire Service, Tübify Foods, SPUD, Smash + Tess, *WERD Magazine*, Momenta[\[35\]](#fn35) | | Lívia Palmerston Mendes | Senior Scientist I, Formulation[\[7:26\]](#fn7) | Federal University of Goiás, Cifarma Científica Farmacêutica, Antimicrobial Discovery Center (ADC), Northeastern University, [CureVac](https://www.whiteroseintelligence.com/CureVac), Controlled Release Society, Abroaders[\[36\]](#fn36) | | Ardalan Nabi | Scientist I, Chemistry[\[7:27\]](#fn7) | UBC Department of Chemistry, Soran University, University of Auckland[\[37\]](#fn37) | | Ariane Nissenbaum | Senior Associate Scientist, RNA[\[7:28\]](#fn7) | Sunnybrook Health Sciences Centre, College of San Mateo (CSM), Atlantis, San Francisco State University, University of California, San Francisco (UCSF), Genentech, UCSF Benioff Children's Hospital at Mission Bay[\[38\]](#fn38) | | Maryam Osooly | Preclinical Research Technician[\[7:29\]](#fn7) | BC Cancer Research Centre (BCCRC) | | Grishma Pawar | Scientist II, Preclinical[\[7:30\]](#fn7) | Krembil Brain Institute (KBI), Maneesh Pharmaceuticals, Vivekanand Education Society College of Pharmacy, Sanofi, Northeastern University, Kalia Labs, University Health Network Postdoc Association (UHNPA), Indian Pharmaceutical Association (IPA)[\[39\]](#fn39) | | Nicola Pett | Preclinical Research Associate[\[7:31\]](#fn7) | University of Calgary, University of Queensland | | Atul Rangadurai | Scientist I, RNA[\[7:32\]](#fn7) | University of Toronto, SickKids, Indian Institute of Science (IISc)[\[40\]](#fn40) | | Eleonore Rayner | Project Manager[\[7:33\]](#fn7) | University of British Columbia (UBC), Hammersmith Medicines Research (HMR), Kastrup Lab, Michael Smith Laboratories[\[41\]](#fn41) | | Fariba Saadati | Senior Scientist III, Chemistry[\[7:34\]](#fn7) | University of British Columbia (UBC), Institute for Advanced Studies in Basic Sciences (IASBS) | | Jessica Silva | Scientist, Preclinical Immunology[\[7:35\]](#fn7) | University of Tennessee at Martin, UBC Department of Microbiology and Immunology, Ronald McDonald House Charities, Phi Eta Sigma, Phi Kappa Phi[\[42\]](#fn42) | | Molly Stevens | Scientific Advisor (Canada) and Board Member (UK)[\[43\]](#fn43) | Imperial College London (ICL), Karolinska Institute, Royal Society, Royal Academy of Engineering, National Academy of Engineering (NAE) | | Anthony Tam | Scientist II, Preclinical Research[\[7:36\]](#fn7) | Vancouver Biotech Limited (VBL), British Columbia Institute of Technology (BCIT), University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Mitacs[\[44\]](#fn44) | | Huy Tran | Scientist II, Chemistry[\[7:37\]](#fn7) | University of Ottawa, Theravance Biopharma, Cytokinetics, Chemistry and Biomolecular Graduate Student Association (CBGSA), Queensway Carleton Hospital[\[45\]](#fn45) | | Xinying Wang | RNA Scientist[\[7:38\]](#fn7) | \- | | John Williams | Company Secretary (UK)[\[7:39\]](#fn7) | Institute of Chartered Accountants in England and Wales (ICAEW) | | Kathy Wong | Research Associate, RNA[\[7:40\]](#fn7) | [British Columbia Centre for Disease Control](https://www.whiteroseintelligence.com/British-Columbia-Centre-for-Disease-Control) (BCCDC) | | Caroline Ye | Senior Scientist I, Formulation[\[7:41\]](#fn7) | [Precision NanoSystems](https://www.whiteroseintelligence.com/Precision-NanoSystems), Imperial College London (ICL), Kastrup Lab, Cat Therapy & Rescue Society[\[46\]](#fn46) | ## Patents - WO 2024/065043 A1: [Amino acid-containing ionizable lipids for the delivery of therapeutics agents](https://web.archive.org/web/20240903221800/https://patentimages.storage.googleapis.com/84/b8/2b/f27fac18e143ab/WO2024065043A1.pdf) - Inventors: Prasad Atmuri, Fariba Saadati, Marco Ciufolini - Agent: Wendy Lamson ## External links - [LinkedIn](https://www.crunchbase.com/organization/nanovation-therapeutics) - [OpenCorporates (Canada)](https://opencorporates.com/companies/ca%5Fbc/BC1264242) - [OpenCorporates (UK)](https://opencorporates.com/companies/gb/13786991) - [Website](https://nanovationtx.com/) --- 1. *NanoVation Therapeutics UK.* Research Complex at Harwell. Retrieved September 11, 2024, from [↩︎](#fnref1) 2. *NMIN spin-off company NanoVation Therapeutics is expanding into UK.* (2022, April 20). Nanomedicines Innovation Network. [↩︎](#fnref2) [↩︎](#fnref2:1) [↩︎](#fnref2:2) [↩︎](#fnref2:3) [↩︎](#fnref2:4) [↩︎](#fnref2:5) 3. OrgBook BC. (2023, October 15). *NanoVation Therapeutics Inc.* OpenCorporates. [↩︎](#fnref3) 4. UK Companies House. (2024, July 1). *NanoVation Therapeutics UK Ltd.* OpenCorporates. [↩︎](#fnref4) 5. *Innovate BC Awards $2.3M to B.C. R&D Projects.* (2022, September 30). Innovate BC. [↩︎](#fnref5) 6. *NanoVation Therapeutics.* Life Sciences British Columbia. Retrieved February 6, 2024, from [↩︎](#fnref6) 7. *Team.* NanoVation Therapeutics. Retrieved September 7, 2024, from [↩︎](#fnref7) [↩︎](#fnref7:1) [↩︎](#fnref7:2) [↩︎](#fnref7:3) [↩︎](#fnref7:4) [↩︎](#fnref7:5) [↩︎](#fnref7:6) [↩︎](#fnref7:7) [↩︎](#fnref7:8) [↩︎](#fnref7:9) [↩︎](#fnref7:10) [↩︎](#fnref7:11) [↩︎](#fnref7:12) [↩︎](#fnref7:13) [↩︎](#fnref7:14) [↩︎](#fnref7:15) [↩︎](#fnref7:16) [↩︎](#fnref7:17) [↩︎](#fnref7:18) [↩︎](#fnref7:19) [↩︎](#fnref7:20) [↩︎](#fnref7:21) [↩︎](#fnref7:22) [↩︎](#fnref7:23) [↩︎](#fnref7:24) [↩︎](#fnref7:25) [↩︎](#fnref7:26) [↩︎](#fnref7:27) [↩︎](#fnref7:28) [↩︎](#fnref7:29) [↩︎](#fnref7:30) [↩︎](#fnref7:31) [↩︎](#fnref7:32) [↩︎](#fnref7:33) [↩︎](#fnref7:34) [↩︎](#fnref7:35) [↩︎](#fnref7:36) [↩︎](#fnref7:37) [↩︎](#fnref7:38) [↩︎](#fnref7:39) [↩︎](#fnref7:40) [↩︎](#fnref7:41) 8. *Pieter Cullis.* NanoVation Therapeutics. Retrieved September 6, 2024, from [↩︎](#fnref8) 9. *Experience | Dominik Witzigmann.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref9) 10. *Volunteering | Dominik Witzigmann.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref10) 11. *Marion Athané.* NanoVation Therapeutics. Retrieved September 6, 2024, from [↩︎](#fnref11) 12. *Experience | Marion Athané.* LinkedIn. Retrieved September 6, 2024, from [https://www.linkedin.com/in/marion-athané-094a6560/details/experience/](https://www.linkedin.com/in/marion-athan%C3%A9-094a6560/details/experience/) [↩︎](#fnref12) 13. *N. D. Prasad Atmuri, Ph.D.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref13) 14. *Hanna Barriga.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref14) 15. *Experience | Marshall Beck.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref15) 16. *Experience | Mayara Brandao.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref16) 17. *David Broemeling.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref17) 18. *Frederick Campbell.* NanoVation Therapeutics. Retrieved September 7, 2024, from [↩︎](#fnref18) 19. *Fred Campbell.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref19) 20. *Tony Cheung.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref20) 21. *Christine DeMatteis.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref21) 22. *Experience | Arpan Desai.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref22) 23. *Experience | Allison Enjetti, MSc.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref23) 24. *Experience | Don Enns.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref24) 25. *Experience | Bruno Fonseca, PhD.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref25) 26. *Georgia Girt.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref26) 27. *Rupsa Gupta.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref27) 28. *Graham Hayes.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref28) 29. *Kate Hollinshead.* NanoVation Therapeutics. Retrieved September 6, 2024, from [↩︎](#fnref29) 30. *Joshua I.R. Jeyakumar.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref30) 31. *Daniel Kurek.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref31) 32. *Wendy Lamson.* LinkedIn. Retrieved September 6, 2024, from [↩︎](#fnref32) 33. *Rafaela Marodin.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref33) 34. *Michelle Martin, CPHR, SHRM-SCP.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref34) 35. *Experience | Nigel McKenzie.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref35) 36. *Lívia Palmerston Mendes.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref36) 37. *Experience | Ardalan Nabi.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref37) 38. *Experience | Ariane Miriam Nissenbaum.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref38) 39. *Grishma Pawar, Ph.D.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref39) 40. *Atul Kaushik Rangadurai, PhD.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref40) 41. *Eleonore Rayner.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref41) 42. *Jessica Silva.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref42) 43. *Molly Stevens.* NanoVation Therapeutics. Retrieved September 7, 2024, from [↩︎](#fnref43) 44. *Anthony T.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref44) 45. *Huy Tran, Ph.D.* LinkedIn. Retrieved September 9, 2024, from [↩︎](#fnref45) 46. *Caroline Ye.* LinkedIn. Retrieved September 10, 2024, from [↩︎](#fnref46)